NCT00037882View on ClinicalTrials.gov

PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron

PHASE2TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

December 3, 2003

Study Completion Date

December 3, 2003

Conditions

Leukemia, Myeloid, Philadelphia-Positive

Interventions

DRUG

PEG-Intron

Once weekly injection.

Trial Locations (1)

77030

M. D. Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT00037882 - PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron | Biotech Hunter | Biotech Hunter